Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Ardelyx initiates two new trials of RDX-7675 for hyperkalemia

Jan. 5, 2017

Vifor Pharma and ChemoCentryx expand kidney health alliance

Dec. 23, 2016

CFDA grants approval for clinical trials of fadanafil

Dec. 16, 2016

Third Rock Ventures launches Goldfinch Bio with a focus on therapies for kidney disease

Dec. 15, 2016

Topline data from phase III PATENCY-1 study of investigational vonapanitase in patients with CKD

Dec. 14, 2016

Blisibimod BRIGHT-SC study demonstrates positive trends in the week 48 analysis

Dec. 9, 2016

Regulus unveils new drug development candidates

Dec. 9, 2016

Anti-APRIL monoclonal antibody developed at Visterra for IgA nephropathy

Dec. 7, 2016

Pharmalink's Nefecon earns orphan drug designation in E.U. for IgAN

Nov. 30, 2016

MonoSol files NDA with FDA for Tadalafil PharmFilm in the treatment of erectile dysfunction

Nov. 29, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...